ASPEN PHARMACARE H.
ASPEN PHARMACARE H.
Share · ZAE000066692 · A0ET80 (XJSE)
Overview
No Price
Closing Price XJSE 09.12.2025: 9.150,00 ZAC
19.12.2025 07:01
Current Prices from ASPEN PHARMACARE H.
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
LDZA.F
EUR
19.12.2025 07:01
4,86 EUR
0,16 EUR
+3,40 %
XHAN: Hannover
Hannover
APHPLC92.HANB
EUR
19.12.2025 07:01
4,86 EUR
0,16 EUR
+3,40 %
XDQU: Quotrix
Quotrix
APHPLC92.DUSD
EUR
19.12.2025 06:27
4,88 EUR
0,18 EUR
+3,83 %
XDUS: Düsseldorf
Düsseldorf
APHPLC92.DUSB
EUR
18.12.2025 18:30
4,78 EUR
0,08 EUR
+1,70 %
XJSE: JSE
JSE
APN.JO
ZAc
09.12.2025 08:30
9.150,00 ZAC
-72,00 ZAC
-0,78 %
OTC: UTC
UTC
APNHF
USD
08.12.2025 21:00
6,23 USD
0,00 USD
Share Float & Liquidity
Free Float 82,45 %
Shares Float 366,1 M
Shares Outstanding 444,02 M
Invested Funds

The following funds have invested in ASPEN PHARMACARE H.:

Fund
iShares MSCI South Africa UCITS ETF USD (Acc)
Vol. in million
2.034,40
Percentage (%)
2,06 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Dist)
Vol. in million
847,93
Percentage (%)
0,38 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Acc)
Vol. in million
9.592,66
Percentage (%)
0,38 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
17,02
Percentage (%)
0,10 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
1.044,27
Percentage (%)
0,09 %
Company Profile for ASPEN PHARMACARE H. Share
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Get up to date insights from finAgent about ASPEN PHARMACARE H.

Company Data

Name ASPEN PHARMACARE H.
Company Aspen Pharmacare Holdings Limited
Website https://www.aspenpharma.com
Primary Exchange XJSE JSE
WKN A0ET80
ISIN ZAE000066692
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Stephen Bradley Saad BCom,
Market Capitalization 3 Mrd.
Country South Africa
Currency EUR
Employees 8,9 T
Address Aspen Place, Durban
IPO Date 2000-01-04

Ticker Symbols

Name Symbol
Over The Counter APNHF
Düsseldorf APHPLC92.DUSB
Frankfurt LDZA.F
Hannover APHPLC92.HANB
JSE APN.JO
Quotrix APHPLC92.DUSD
More Shares
Investors who hold ASPEN PHARMACARE H. also have the following shares in their portfolio:
DT.TELEK.INTL F.08/23 MTN
DT.TELEK.INTL F.08/23 MTN Bond
Hilton BDC Corporate Bond ETF
Hilton BDC Corporate Bond ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025